We came across a bullish thesis on Harrow, Inc. on Penny Insight’s Substack. In this article, we will summarize the bulls’ thesis on HROW. Harrow, Inc.'s share was trading at $38.23 as of August 19th. HROW’s trailing and forward P/E were 9.64 and 3.33k respectively according to Yahoo Finance.
[caption id="attachment_970273" align="aligncenter" width="768"]Harrow, Inc. is a U.S.-based ophthalmology pharmaceutical company rapidly expanding its branded portfolio with products such as VEVYE, IHEEZO, TRIESENCE, and the...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.